[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100571915":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":29,"centralContacts":34,"locations":39,"responsibleParty":55,"collaborators":10,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":10,"eligibilityCriteria":63,"healthyVolunteers":59,"sex":64,"minAge":65,"maxAge":10,"enrollmentInfo":66,"targetDuration":10,"studyType":69,"phases":10,"briefSummary":70,"conditions":71,"keywords":75,"overallStatus":41,"whyStopped":10,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":89},{"fullName":5,"class":6},"Zhujiang Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Group 1: Nova Group",null,"This group involves the use of the Nova Stat Profile pHOx Ultra Analyzer System for measuring serum and whole blood samples. The results obtained from Nova will be compared with those obtained from P1.",[13],"Diagnostic Test: Nova Stat Profile pHOx Ultra Analyzer System(Nova)",{"label":15,"type":10,"description":16,"interventionNames":17},"Group 1: P1 Group","This group involves the use of the novel POCT dry electrolyte analysis system P1 for measuring serum and whole blood samples. The results obtained from P1 will be compared with those obtained from Nova.",[18],"Diagnostic Test: Novel POCT dry electrolyte analysis system(P1)",[20,25],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":10},"DIAGNOSTIC_TEST","Nova Stat Profile pHOx Ultra Analyzer System(Nova)","This group involves the use of Nova for measuring serum and whole blood samples. The results from Nova will be compared with those obtained from P1.",[9],{"type":21,"name":26,"description":27,"armGroupLabels":28,"otherNames":10},"Novel POCT dry electrolyte analysis system(P1)","This group involves the use of P1 for measuring serum and whole blood samples. The results from P1 will be compared with those obtained from Nova.",[15],[30],{"name":31,"affiliation":32,"role":33},"Hua Xie","Zhujiang Hospital, Southern Medical University Organization","PRINCIPAL_INVESTIGATOR",[35],{"name":31,"role":36,"phone":37,"phoneExt":10,"email":38},"CONTACT","+86 19802050526","52528316@qq.com",[40],{"facility":32,"status":41,"city":42,"state":43,"zip":44,"country":45,"countryCode":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":53},"RECRUITING","Guangzhou","Guangdong","510000","China","CN",{"type":48,"coordinates":49},"Point",[50,51],113.25,23.11667,{"lat":51,"lon":50},[54],{"name":31,"role":36,"phone":37,"phoneExt":10,"email":38},{"type":56,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100571915","validation-of-the-accuracy-of-a-novel-poct-dry-electrolyte-analysis-system-in-the-acute-care-setting-100571915",false,"NCT06726460","Validation of the Accuracy of a Novel POCT Dry Electrolyte Analysis System in the Acute Care Setting","Validation of the Accuracy of a Novel POCT Dry Electrolyte Analysis System in the Acute Care Setting: A Cross-Sectional Study","Inclusion Criteria:\n\n* Patients who are scheduled to undergo electrolyte measuring in the emergency department (ED) or emergency intensive care unit (ICU).\n\nExclusion Criteria:\n\n* Patients with a confirmed history of infectious diseases such as hepatitis B, syphilis, HIV\u002FAIDS, etc.\n* Missing residual sample types (serum or whole blood).\n* Patients whose residual blood samples are not tested within the specified time frame after collection.\n* Other patients deemed ineligible by the investigator.","ALL","28 Days",{"count":67,"type":68},200,"ESTIMATED","OBSERVATIONAL","The goal of this study is to compare the performance of a novel Point-of-Care Testing (POCT) dry electrolyte analyzer (P1) with the Nova Stat Profile pHOx Ultra Analyzer System (Nova) in an acute care setting. The main questions it aims to answer are:\n\n1. How consistent are the results between P1 and Nova in the emergency setting, including outliers, correlation, linearity, and bias?\n2. Whether P1 can serve as a suitable alternative to Nova in the acute care setting for electrolyte measurement in the emergency environment.\n\nParticipants will be patients in the emergency department who will undergo simultaneous measurement with P1 and Nova during their emergency care to assess the performance of both devices.\n\nAdditionally, the study will investigate electrolyte levels in emergency patients, focusing on the prevalence of abnormal ionized magnesium (iMg2+) levels, the correlation between iMg2+ and total magnesium (tMg), and the clinical significance of iMg2+ measurement.",[72,73,74],"Electrolyte Disorder","Arrhythmia","Stroke",[76,77,78,79],"Electrolyte Analyzer","Accuracy","P1","Eaglenos","2025-07-15",{"date":82,"type":83},"2025-07-18","ACTUAL",{"date":85,"type":83},"2024-12-17",{"date":87,"type":68},"2025-10-31",{"name":5,"class":6},1]